Paper: Safety and efficacy of sitagliptin added to insulin in Type 2 Diabetes (2009 ACCP/ESCP International Congress on Clinical Pharmacy (April 24

Saturday, April 25, 2009

Benjamin Dropkin, Pre-Med , Hamilton College, Clinton, NY

Andrea N. Traina, Pharm.D. , Albany College of Pharmacy and Health Sciences, Albany, NY

Michael P. Kane, Pharm.D. , Albany College of Pharmacy and Health Sciences, Albany, NY

Robert S. Busch, M.D. , The Endocrine Group, LLP, Albany, NY

Gary Bakst, M.D. , The Endocrine Group, LLP, Albany, NY

Jill M. Abelseth, M.D. , The Endocrine Group, LLP, Albany, NY

Robert A. Hamilton, Pharm.D. , Albany College of Pharmacy and Health Sciences, Albany, NY

254 Safety and efficacy of sitagliptin added to insulin in Type 2 Diabetes